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Epilepsy is increasingly conceptualized as a network disorder. In this cross-sectional mega-analysis, we integrated 
neuroimaging and connectome analysis to identify network associations with atrophy patterns in 1021 adults 
with epilepsy compared to 1564 healthy controls from 19 international sites. In temporal lobe epilepsy, areas of 
atrophy colocalized with highly interconnected cortical hub regions, whereas idiopathic generalized epilepsy 
showed preferential subcortical hub involvement. These morphological abnormalities were anchored to the 
connectivity profiles of distinct disease epicenters, pointing to temporo-limbic cortices in temporal lobe epilepsy 
and fronto-central cortices in idiopathic generalized epilepsy. Negative effects of age on atrophy further revealed 
a strong influence of connectome architecture in temporal lobe, but not idiopathic generalized, epilepsy. Our 
findings were reproduced across individual sites and single patients and were robust across different analytical 
methods. Through worldwide collaboration in ENIGMA-Epilepsy, we provided deeper insights into the macroscale 
features that shape the pathophysiology of common epilepsies.
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INTRODUCTION
Perpetual interactions among neuronal populations through the 
scaffold of axonal pathways promote interregional communication 
and shape the brain’s structural and functional network organiza-
tion (1). This architecture facilitates efficient communication within 
the brain and may therefore be profoundly affected by pathological 
perturbations (2). Adopting network science can advance under-
standing of widespread pathophysiological effects in prevalent 
disorders and improve diagnostics and prognostication.
The application of neuroimaging to study common epilepsy 
syndromes has paradigmatically shifted from a focus on individual 
regions to approaches highlighting network effects, exemplified by 
classically defined focal epilepsies, such as temporal lobe epilepsy 
[TLE; (3, 4)]. While initial work focused on the mesiotemporal lobe, 
histopathological and neuroimaging studies increasingly detail 
morphological, structural, and functional compromise beyond this 
region (5–8), which becomes progressively more severe in patients 
with longer disease duration (9–12). Conversely, idiopathic gener-
alized epilepsy (IGE), also known as genetic generalized epilepsy, has 
been increasingly linked to subtle degrees of structural compromise, 
mainly in subcortico-cortical circuits (13–16). Support for a network 
perspective also comes from both experimental studies in animal 
models and electro-clinical observations in patients showing bursts of 
spike and slow-wave discharges occurring simultaneously over sub-
cortical and cortical areas (17, 18). Complementing these observations, 
basal ganglia atrophy as well as functional changes of the caudate and 
putamen have been previously noted but warrant further investiga-
tion to solidify the understanding of network disruptions in IGE (19, 20).
Initiatives such as the Human Connectome Project [HCP; (21)] 
provide normative structural and functional connectivity informa-
tion from a large sample of healthy individuals. Studying network 
underpinnings of morphological abnormalities may elucidate brain- 
wide mechanisms in focal and generalized epilepsies. Hub regions 
(i.e., nodes with many connections) are a cardinal feature of brain 
networks and serve as relays to efficiently process and integrate in-
formation (22, 23). Their high centrality, however, also makes them 
vulnerable to pathological processes—the so-called nodal stress 
hypothesis (2). Neurodegenerative and psychiatric research has demon-
strated that hubs typically show greater atrophy than locally connected 
peripheral nodes. This increased susceptibility to structural damage 
likely stems from their high metabolic activity and their association 
with multiple brain networks (1, 24). We anti cipate that models of 
regional susceptibility can yield substantial advances toward our 
understanding of how connectome architecture configures, to some 
extent, gray matter atrophy in the common epilepsies.
Complementing the nodal stress hypothesis, in which patterns 
of cortical atrophy and hub regions appear spatially concomitant, 
disease epicenter mapping can identify one or more specific regions— 
or epicenters—whose connectivity profile may play a central role in 
the whole-brain manifestation of focal and generalized epilepsies 
(24, 25). Among common epilepsies, application of these models to 
TLE and IGE is justified as both syndromes have been associated 
with pathophysiological anomalies in mesiotemporal and subcortico- 
cortical networks and represent conceptual extremes of a focal to 
generalized continuum of epilepsy subtypes (14, 15, 26). Disease 
epicenter mapping in TLE and IGE may therefore identify syndrome- 
specific network-level substrates and provide deeper insights into 
how epilepsy-related atrophy patterns are anchored to the connec-
tivity of specific structural and functional subnetworks.
The current work tested the hypothesis that brain network ar-
chitecture governs whole-brain atrophy in TLE and IGE. Cortical 
and subcortical gray matter atrophy patterns were mapped across 
19 international sites via ENIGMA-Epilepsy (27). We also lever-
aged the HCP dataset to derive high-resolution structural and func-
tional normative brain networks. Two classes of network-based 
models tested whether, and how, healthy connectome architecture 
can predict regional susceptibility in the common epilepsies. Our 
evaluations included (i) nodal stress models, which assessed 
whether there is a selective vulnerability of hub regions that paral-
lels syndrome- specific atrophy patterns, and (ii) disease epicenter 
mapping, which explored the influence of every brain region’s 
connectivity profile on the spatial distribution of gray matter atro-
phy in TLE and IGE. In both cases, model fit was assessed against 
null models with similar spatial autocorrelation (28). To demon-
strate clinical relevance, we investigated whether these network- 
level features could predict spatial patterns of disease duration 
and age-related effects. We also formulated a patient-tailored ad-
aptation of our network-based models to examine whether 
network-derived spatial predictors were translatable to individual 
patients.
RESULTS
Data samples
We studied 1021 adult patients with epilepsy (440 males, mean age ± 
SD = 36.72 ± 11.07 years) and 1564 healthy controls (695 males, 
mean age ± SD = 33.13 ± 10.45 years) from 19 centers in the inter-
national Epilepsy Working Group of ENIGMA (29). Our main 
analyses focused on two patient subcohorts with site-matched 
healthy controls: TLE with neuroradiological evidence of hippo-
campal sclerosis (nHC/TLE = 1418/732, 341 right-sided focus) and 
IGE (nHC/IGE = 1075/289). Details on subject inclusion and case- 
control subcohorts are provided in Materials and Methods and 
Table 1. Site-specific demographic information is provided in table S1. 
All participants were aged between 18 and 70 years.
Cortical and subcortical atrophy in the common epilepsies
While the original ENIGMA-Epilepsy study performed a meta- 
analysis of statistical results submitted by the individual sites, the 
current study directly analyzed cortical surface and subcortical vol-
ume data in all patients and controls. Cortical thickness was mea-
sured across 68 gray matter brain regions, and volumetric measures 
were obtained from 12 subcortical gray matter regions and bilateral 
hippocampi based on the Desikan-Killiany anatomical atlas (30). 
Surface-based linear models compared atrophy profiles in patients 
relative to controls, correcting for multiple comparisons using the 
false discovery rate (FDR) procedure (31).
Mirroring ENIGMA-Epilepsy’s meta-analysis of summary sta-
tistics comparing neurologically healthy controls to patients with 
epilepsy, our mega-analysis also revealed widespread cortico- 
subcortical atrophy patterns in TLE and IGE syndromes. Specif-
ically, patients with TLE showed profound atrophy in bilateral 
precuneus (PFDR < 4 × 10−36), precentral (PFDR < 8 × 10−36), para-
central (PFDR < 6 × 10−29), and superior temporal (PFDR < 3 × 10−14) 
cortices as well as ipsilateral hippocampus (PFDR < 2 × 10−199) and 
thalamus (PFDR < 5 × 10−64; Fig. 1A). In contrast, patients with 
IGE showed atrophy predominantly in bilateral precentral cortices 
(PFDR < 9 × 10−10) and the thalamus (PFDR < 3 × 10−6; Fig. 1B).
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Nodal stress models predict regional susceptibility
Having established patterns of atrophy in TLE and IGE, we eval-
uated whether these abnormalities were associated with normative 
network organization. To this end, we obtained high-resolution 
structural (derived from diffusion-weighted tractography) and 
functional [derived from resting-state functional magnetic reso-
nance imaging (fMRI)] connectivity data from a cohort of unre-
lated healthy adults from the HCP dataset (21). Details on subject 
inclusion and matrix generation are provided in Materials and 
Methods.
Echoing established network centrality maps in healthy individ-
uals (22, 23), hub regions in the HCP dataset predominated in 
medial prefrontal, superior parietal, and angular regions (Fig. 2A). 
Nodal stress models, in which spatial similarity between syndrome- 
related atrophy patterns and degree centrality was compared through 
correlation analysis (and statistically assessed via nonparametric spin 
permutation tests; see Materials and Methods), revealed that cor-
tical thinning in TLE implicated functional [correlation coefficient 
(r) = 0.69, Pspin < 0.0005] and marginally structural (r = 0.27, 
Pspin = 0.07) cortico-cortical hubs more strongly than nonhub regions 
Table 1. ENIGMA Epilepsy Working Group demographics. Demographic breakdown of patient-specific subcohorts with site-matched controls, including age 
(in years), age at onset of epilepsy (in years), sex, side of seizure focus (patients with TLE only), and mean duration of illness (in years). Healthy controls from sites 
that did not have TLE (or IGE) patients were excluded from analyses comparing TLE (or IGE) to controls. 
Case-control 
subcohorts Age (means ± SD)
Age at onset 
(means ± SD) Sex (male/female) Side of focus (L/R)
Duration of illness 
(means ± SD)
TLE (n = 732) 38.56 ± 10.61 16.07 ± 12.27 329/403 391/341 22.74 ± 14.06*
HC (n = 1418) 33.76 ± 10.54 – 643/775 – –
IGE (n = 289) 32.06 ± 10.85 16.84 ± 11.25 111/178 – 15.09 ± 11.70*
HC (n = 1075) 31.41 ± 9.59 – 454/621 – –
 *Information available in 695 of 732 patients with TLE and 250 of 289 patients with IGE.
Fig. 1. Cortical thickness and subcortical volume in TLE and IGE. (A) Cortical thickness and subcortical volume reductions in TLE (n = 732), compared to healthy con-
trols (n = 1418), spanned bilateral precuneus (PFDR < 4 × 10−36), precentral (PFDR < 8 × 10−36), paracentral (PFDR < 6 × 10−29), and superior temporal (PFDR < 3 × 10−14) cortices 
and ipsilateral hippocampus (PFDR < 2 × 10−199) and thalamus (PFDR < 5 × 10−64). (B) In contrast, gray matter cortical and subcortical atrophy in IGE (n = 289), relative to 
controls (n = 1075), was more subtle and affected predominantly bilateral precentral cortical regions (PFDR < 9 × 10−10) and the thalamus (PFDR < 3 × 10−6). Negative 
log10-transformed FDR-corrected P values are shown.
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(Fig. 2B). In contrast, in IGE, stronger relationships were observed 
between subcortical volume decreases and structural (r = 0.68, 
Pshuf < 0.01) and marginally functional (r = 0.50, Pshuf = 0.06) 
subcortico-cortical hubs (Fig. 2B). To verify stability, we repeated 
the above correlations across several graph-based nodal metrics (in-
cluding pagerank centrality and eigenvector centrality) and captured 
virtually identical associations between atrophy patterns and network 
centrality measures (fig. S1).
TLE and IGE have distinct disease epicenters
Since hub regions are more susceptible to atrophy than nonhub 
regions, we next investigated whether epilepsy-related cortical 
thickness abnormalities were anchored to the connectivity profile 
of one or more brain regions. To detect syndrome-specific disease 
epicenters, we systematically compared every region’s functional and 
structural connectivity profiles to whole-brain patterns of atrophy 
in TLE and IGE and assessed significance of rankings using spin 
permutation tests. Cortical and subcortical regions were ranked in 
descending order based on their correlation coefficients, with highly 
ranked—and statistically significant—regions being identified as 
disease epicenters. Disease epicenters thus represented regions whose 
functional and structural connectivity profile spatially resembled 
the epilepsy-related atrophy maps (Fig. 3A).
In TLE, spatial correlations between atrophy maps and seed-
based functional and structural connectivity profiles implicated 
ipsilateral temporo-limbic cortices (Pspin < 0.05) and several ipsilat-
eral subcortical regions as disease epicenters (Pspin < 0.05; Fig. 3B). 
Conversely, bilateral fronto-central cortices and the amygdala emerged 
as epicenters in IGE (Pspin < 0.05; Fig. 3C). Although highest ranked 
functional and structural epicenters in TLE and IGE were not hubs 
themselves (as defined by the top 10% of high-degree nodes), they 
were significantly connected to hub regions (range of spatial cor-
relations between epicenter-based connectivity and maps of degree 
centrality: rfunctional = 0.67 to 0.77, Pspin < 0.0001; rstructural = 0.27 to 
0.31, Pspin < 0.09), effectively making them feeder nodes, that is, 
peripheral nodes that are directly linked to hubs.
Fig. 2. Epilepsy-related atrophy correlates with hub organization. (A) Normative functional and structural network organization, derived from the HCP dataset, was 
used to identify hubs (i.e., regions with greater degree centrality). (B) Schematic of the figure layout is pictured in the middle. Gray matter atrophy related to node-level 
functional (left) and structural (right) maps of degree centrality, with greater atrophy in hub compared to nonhub regions. Stratifying findings across TLE and IGE, we 
observed stronger associations between cortico-cortical functional hubs and cortical atrophy patterns in TLE (Pspin < 0.0001) and between subcortical volume loss and 
subcortico-cortical structural hubs in IGE (Pshuf < 0.01).
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Effects of age and disease duration
We adapted the above-described nodal stress and epicenter mapping 
models to disentangle network factors that contribute to cross- 
sectional markers of age and disease duration effects. Using linear 
models, we first examined effects of age and disease duration on 
morphological measures within each patient cohort, paralleling 
approaches from earlier work (12). Patients with TLE showed a 
negative effect of age on cortical thickness primarily in bilateral 
temporo-parietal (PFDR < 0.005) and sensorimotor cortices (PFDR < 0.01) 
as well as on subcortical volume mainly in ipsilateral hippocampus 
(PFDR < 5×10−7) and bilateral thalamus (PFDR < 0.05; Fig. 4A). Com-
paring these patterns to structural and functional degree centrality 
and epicenter maps, strongest correlations were seen with functional 
cortico- and subcortico-cortical hubs (rs = 0.64 to 0.65, Pshuf/spin < 
0.05) and with functional and structural cortical disease epicenters 
(rs = 0.44 to 0.66, Pspin < 0.05; Fig. 4B). The main effect of disease 
duration on atrophy patterns colocalized with regions emerging from 
the group × age interaction (e.g., bilateral superior parietal cortex, 
contralateral postcentral gyrus, and ipsilateral hippocampus and 
thalamus, PFDR < 0.01; fig. S2A). While duration effects also showed 
tendencies for positive correlations with normative network cen-
trality and epicenter values, effects were not significant (fig. S2B).
In IGE, there were no significant effects of aging (fig. S3A) or 
disease duration (fig. S4A) on cortical and subcortical atrophy mea-
sures nor of correlations with degree centrality and epicentral maps 
(figs. S3B and S4B). There was a trend toward the negative effects of 
aging and duration of illness on gray matter atrophy, particularly 
affecting bilateral temporo-parietal and fronto-central cortices 
(Puncorr < 0.05), as well as right amygdala (Puncorr < 0.1). Exploring 
the effects of age at onset on morphological abnormalities yielded 
virtually identical findings in TLE (fig. S5A) and IGE (fig. S5B), 
independently.
Patient-tailored atrophy modeling
We adjusted our network-based models to assess whether norma-
tive connectivity organization configures atrophy patterns in indi-
vidual patients. To do so, we first correlated patient-specific gray 
matter atrophy maps with normative centrality metrics. We subse-
quently identified each patient’s structural and functional disease 
epicenters by keeping brain regions whose healthy connectivity 
profiles significantly correlated with the patient’s atrophy map.
Although this was expected to result in lower sensitivity due to 
the increased heterogeneity in atrophy patterns, we observed similar 
associations between individualized atrophy maps and cortical degree 
centrality as seen in the group-level analysis. Notably, most stable 
associations in patients with TLE were seen between functional 
cortico-cortical hubs and cortical atrophy (Pspin < 0.05 in 22.4% of 
individuals with TLE), whereas most stable relations in patients 
with IGE were observed between structural cortico-cortical hubs 
and cortical atrophy (Pspin < 0.05 in 15.2% of individuals with IGE; 
Fig. 5A). Similarly, epicenter results were consistently seen in indi-
vidual patients, with ipsilateral temporo-limbic and subcortical re-
gions most often emerging as epicenters in TLE, whereas bilateral 
fronto-central regions, including sensorimotor cortices, were most 
often identified as epicenters in IGE (Fig. 5B).
Findings were robust across a range of sensitivity analyses
Dominant patterns of atrophy in bilateral precuneus (PFDR < 2 × 10−25), 
superior parietal (PFDR < 3 × 10−24), and precentral (PFDR < 5 × 10−22) 
cortices as well as ipsilateral hippocampus (PFDR < 8 × 10−125) and 
thalamus (PFDR < 6 × 10−37; fig. S6A) were observed when compar-
ing left and right TLE cohorts separately to controls. Left TLE addi-
tionally showed gray matter reductions in ipsilateral lateral and 
mesiotemporal cortices (PFDR < 2 × 10−15) and the bilateral thalamus 
(PFDR < 6 × 10−23). This distinction did not affect the relationship 
between atrophy patterns and functional cortico-cortical hub dis-
tribution (rLTLE = 0.61, Pspin < 0.005; rRTLE = 0.72, Pspin < 0.0001; 
fig. S6B). Functional and structural epicenters in both left and right 
TLE were localized in mesiotemporal and sensorimotor cortices 
(fig. S6C), but differed across subcortical areas, with the ipsilateral 
hippocampus emerging as putative disease epicenter in left, but not 
right, TLE (rfunctional = 0.38, Pspin = 0.05; rstructural = 0.30, Pspin = 0.09). 
Although negative effects of age on cortical thickness in bilateral 
visual (PFDR < 0.001) and superior temporal (PFDR < 0.005) cortices 
were common to both left and right TLE, right TLE showed more 
widespread group × age interaction effects, particularly affecting 
bilateral parietal cortex (PFDR < 0.01) and the ipsilateral hippo-
campus (PFDR < 3×10−8), amygdala (PFDR < 0.001), and thalamus 
(PFDR < 0.005). Nevertheless, associations between age-related ef-
fects and hub and disease epicenter distributions remained virtually 
identical in left and right TLE (fig. S6D).
Syndrome-specific cortical and subcortical atrophy maps were 
consistent across sites and similar to those obtained from the multisite 
aggregation for both TLE (fig. S7A) and IGE (fig. S7B). The highest 
stability in TLE was observed for correlations of atrophy with func-
tional cortico- and subcortico-cortical degree centrality (means ± SD: 
r = 0.33 ± 0.24 and means ± SD: r = 0.43 ± 0.26, respectively; fig. S7C). 
Conversely, stability in IGE was the highest for correlations with 
structural subcortico-cortical degree centrality (means ± SD: r = 
0.28 ± 0.22; fig. S7D). As observed in the multisite findings, site- 
specific ipsilateral temporo-limbic regions and subcortical areas 
were most often identified as disease epicenters in TLE (fig. S7E), 
whereas bilateral fronto-central cortices, amygdala, and thalamus 
most frequently emerged as disease epicenters in IGE (fig. S7F).
Our findings were not affected by varying specific matrix thresh-
olds: Across the range of possible thresholds, we observed highly 
consistent associations between atrophy patterns and (i) functional 
cortico-cortical hubs (TLE) and structural subcortico-cortical hubs 
(IGE; fig. S8A) and (ii) functional and structural epicenter-based 
connectivity profiles (fig. S8B). Moreover, we observed comparable 
associations between morphological abnormalities and hub (fig. S9A) 
and epicenter (fig. S9, B and C) distributions obtained from a higher- 
resolution functional parcellation [Schaefer 400 parcels (32)].
DISCUSSION
Capitalizing on the largest multisite epilepsy neuroimaging dataset 
to date, we tested the hypothesis that gray matter atrophy patterns 
in TLE and IGE are related to the brain’s connectome architecture. 
First, we found that hub regions were overall more susceptible to 
epilepsy-related atrophy in both TLE and IGE, with cortical hubs 
most affected in TLE and subcortico-cortical hubs most vulnerable 
in IGE. These morphological abnormalities were anchored to the 
connectivity profiles of distinct regions, pointing to temporo-limbic 
disease epicenters in TLE and fronto-central cortices epicenters in 
IGE. Assessing negative effects of age on atrophy further revealed a 
dichotomy between TLE and IGE, with a stronger influence of con-
nectome architecture on how the disease unfolds in TLE. Using a 
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patient-tailored adaptation of our network-based models, we con-
firmed that relationships between atrophy and normative connec-
tivity organization were translatable to individual patients. Findings 
were highly consistent across sites and methodologies, suggesting 
robustness and generalizability.
Our study extends prior research by revealing shared and dis-
tinct network descriptors of atrophy seen in TLE and IGE (29). 
Using a mega-analytic approach, we showed that patients with TLE 
presented with multi-lobar atrophy, affecting fronto-parietal cortices, 
the hippocampus, and the thalamus, extending into lateral temporal 
and mesiotemporal cortices in left, but not right, TLE. In contrast, 
patients with IGE presented with more subtle atrophy in the senso-
rimotor cortex and thalamus, despite having “normal” clinical MRIs 
(29, 33). While prior works in histology, electrophysiology, and 
neuroimaging have provided qualitative descriptions of disease, here, 
we developed network-based models to systematically examine the 
selective vulnerability of brain regions in the common epilepsies. 
This approach revealed that epilepsy-related atrophy patterns could 
be predicted from connectome-derived information, suggesting a 
vulnerability of functional cortical hubs to more pronounced atro-
phy in TLE, regardless of seizure focus laterality, and an increased 
susceptibility of structural subcortical hubs in IGE. Albeit less pro-
nounced, similar trends were also observed for an increased vulner-
ability of structural cortical hubs in TLE and functional subcortical 
hubs in IGE. This implies that TLE and IGE—despite showing 
syndrome-specific atrophy patterns—may share common patho-
physiological features that result in greater atrophy severity in hub 
regions. Irrespective of cortical or subcortical involvement, the 
vulnerability of hub regions to gray matter atrophy can be partly 
ascribed to their disproportionate number of connections and dif-
fuse effect on structural and functional networks (2). Thus, a targeted 
hub attack, as in the case of epilepsy-related atrophy, may fragment 
and segregate the network, favoring recurrent seizure activity in 
TLE and IGE (34, 35).
To elucidate how gray matter atrophy targets hub regions in TLE 
and IGE, we tested the hypothesis that the underlying connectivity 
of specific regions—or epicenters—constrains syndrome-specific 
patterns of atrophy. Each epilepsy syndrome harbored distinct 
Fig. 3. Syndrome-specific disease epicenters. (A) Disease epicenter mapping schema. Spatial correlations between cortical atrophy patterns and seed-based cortico- 
and subcortico-cortical connectivity were used to identify disease epicenters in TLE and IGE. Epicenters are regions whose connectivity profiles significantly correlated 
with the syndrome-specific atrophy map; statistical significance was assessed using spin permutation tests. This procedure was repeated systematically to assess the 
epicenter value of every cortical and subcortical region, as well as in both functional and structural connectivity matrices. (B and C) Correlation coefficients indexing 
spatial similarity between TLE- and IGE-specific atrophy and seed-based functional (left) and structural (right) connectivity measures for every cortical and subcortical 
region. Regions with significant associations were ranked in descending order based on their correlation coefficients, with the first five regions identified as disease 
epicenters (white outline). In TLE, ipsilateral temporo-limbic cortices (functional: Pspin < 0.05, structural: Pspin < 0.1) and subcortical areas—including ipsilateral amygdala 
(functional: Pspin < 0.05), thalamus (functional: Pspin < 0.05, structural: Pspin < 0.01), pallidum (functional: Pspin < 0.05), putamen (functional: Pspin < 0.05), and hippocampus 
(functional: Pspin < 0.1)—emerged as disease epicenters. In IGE, the highest ranked disease epicenters were located in bilateral fronto-central cortices, including postcentral 
gyri (functional: Pspin < 0.05, structural: Pspin < 0.05), left (functional: Pspin < 0.005, structural: Pspin < 0.1) and right amygdala (functional: Pspin < 0.005), and left pallidum 
(structural: Pspin < 0.1). *Pspin < 0.1, n.s., nonsignificant.
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epicenters reflecting its own pathophysiology: Temporo-limbic cor-
tical regions, ipsilateral to the seizure focus, emerged as epicenters 
of atrophy in TLE, whereas fronto-central cortices, specifically senso-
rimotor areas, were identified as disease epicenters in IGE. Although 
the hippocampus is often considered central to seizure generation 
and propagation in TLE (36), it was only identified as a disease epi-
center in left TLE, likely due to its strong connections to lateral 
temporal and mesiotemporal cortex—regions of high atrophy in 
left, but not right, TLE. Marked damage in other mesiotemporal 
and limbic structures such as the entorhinal, piriform, and temporo- 
polar cortex has also been observed in subgroups of TLE and may 
thus contribute to variable disease expression within the broader 
Fig. 4. Negative effects of age on cortical thickness and subcortical volume in TLE. (A) Significant age-related differences on gray matter atrophy between individuals 
with TLE and healthy controls for all cortical and subcortical regions. Patients with TLE showed a negative effect of age on cortical thickness in bilateral temporo-parietal 
(PFDR < 0.005) and sensorimotor (PFDR < 0.01) cortices and on subcortical volume in ipsilateral hippocampus (PFDR < 5 × 10−7) and bilateral thalamus (PFDR < 0.05). Negative 
log10-transformed FDR-corrected P values are shown. (B) Schematic of the figure layout is provided in the middle. Scatterplots depict relationships between the 
age-related effects and functional (red) and structural (blue) maps of degree centrality (left) and disease epicenter (right). Significant associations were observed between 
age-related effects and every hub and epicenter measures, with the exception of structural subcortical degree centrality, suggesting a role of connectome organization 
on age-related effects in TLE.
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Fig. 5. Patient-tailored atrophy modeling. (A) Patient-specific associations between degree centrality (denoting hub distribution) and individualized atrophy maps 
showed high stability between functional cortico-cortical hubs and cortical atrophy in TLE (Pspin < 0.05 in 22.4% of patients) and high stability between structural 
cortico-cortical hubs and cortical atrophy in IGE (Pspin < 0.05 in 15.2% of patients). (B) We identified patient-specific structural and functional disease epicenters by 
keeping brain regions whose connectivity profiles significantly correlated with the patient’s atrophy map (Pspin < 0.05). In TLE, ipsilateral temporo-limbic regions and 
subcortical areas (including the hippocampus) were most often identified as epicenters of gray matter atrophy, whereas in IGE, bilateral fronto-central (including 
sensorimotor cortices) and subcortical areas most often emerged as disease epicenters. Disease epicenters in individual patients strongly resembled those seen across 
the group as a whole.
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umbrella of TLE (5, 37). Moreover, syndrome-specific epicenters were 
not hub regions themselves but were found to be functionally and 
structurally connected to hubs via feeder connections, suggesting dif-
ferential mechanisms through which atrophy may spread to hub 
regions in TLE and IGE. Our findings are compatible with a model 
where epilepsy-related atrophy initially targets syndrome-specific 
epicenters and subsequently propagates to hub regions, which are 
generally more susceptible than nonhubs due to a combination of 
hyperactivation, increased metabolic stress, and being at the cross-
roads of multiple brain networks (2). Future longitudinal studies, 
however, will be needed to provide causal support.
Similar to the hub susceptibility findings, our epicenter ap-
proach revealed a differential sensitivity of functional and structural 
connectivity to TLE- and IGE-specific pathophysiology. Specifically, 
network associations to functionally derived cortical hubs and 
disease epicenters were stronger in TLE, whereas associations to 
structurally derived subcortical hubs and disease epicenters were 
most significant in IGE. Diffusion MRI is particularly sensitive to 
strong long-range fiber bundles and direct monosynaptic structural 
connections but has, unlike resting-state functional MRI, limitations 
in resolving short-range intracortical and spatially distributed poly-
synaptic cortical systems (38). In this context, resting-state functional 
MRI allows for the detection of functional connectivity in the absence 
of direct structural connections and may thus be more informative 
about polysynaptic configurations (38). Functionally derived disease 
epicenters in TLE preferentially detected network associations in 
polysynaptic temporo-limbic areas, whereas structural epicenters 
converged in superior temporal and sensorimotor cortices. In con-
trast, disease epicenters in IGE appeared stable across both functional 
and structural connectomes, likely reflecting network alterations in 
regions with direct structural connections.
Taking advantage of large patient cohorts with heterogeneous 
duration of epilepsy and a wide age range, we could infer the effect 
of duration of illness on gray matter atrophy and separate out neg-
ative age-related effects in epilepsy from that of normal aging. In 
TLE, age × group interaction findings affected atrophy in temporo- 
parietal and sensorimotor cortices, as well as the ipsilateral hippo-
campus and thalamus, as has been previously noted (9–12). Our 
findings suggest that age-related pathophysiological processes follow 
the spatial distribution of hub and epicentral regions in temporal 
lobe, but not idiopathic generalized, epilepsy. We thus speculate 
that connectome architecture exerts a strong influence on the spread 
of epilepsy-related cortical damage in patients with TLE. Mecha-
nisms underlying age-related effects on atrophy in TLE remain in-
completely understood but may relate to a combination of factors, 
including seizure-related excitotoxicity and interictal epileptic ac-
tivity (39), adverse effects from antiepileptic drugs (40), and psy-
chosocial impairments (41). Age-related and disease duration effects 
on atrophy findings in IGE—and links to network centrality measures 
and disease epicenters—were less conclusive. More subtle effects on 
brain structure in IGE may reflect a less severe disease trajectory 
compared to focal epilepsy syndromes and may also arise from the 
intrinsic heterogeneity across generalized syndromes. It is also pos-
sible that generalized epileptiform discharges and seizures diffuse the 
negative consequences of recurrent pathophysiological activity and 
that no single neuronal population bears the brunt of this activity.
Several sensitivity analyses suggested that our findings were not 
affected by differences in scanners or sites or graph theoretical met-
rics. Site and scanner effects were mitigated for the most part using 
ComBat, a post-acquisition statistical batch normalization process 
used to harmonize between-site and between-protocol morpho-
logical variations (42). Associations between normative network 
features and morphological abnormalities, as well as the identifica-
tion of disease epicenters, were also consistently observed in each 
site independently. Repeating our analyses across different graph 
theoretical metrics, matrix densities, and parcellation resolutions 
yielded virtually identical findings, indicating method invariance of 
our results. While our big data effort was predominantly based on 
group-level analyses, findings were replicated using patient-specific 
atrophy maps. Further developed, patient-tailored atrophy models 
may justify optimism in translating insights from large-scale infer-
ence to individual patients, with potential to improve personalized 
prognostics, treatment monitoring, and epilepsy surgery planning.
We wish to emphasize that our work was made possible by 
open-access consortia such as the ENIGMA Epilepsy Working 
Group (29) and the HCP (21). Although HCP provides a bench-
mark dataset for structural and functional connectomes in healthy 
adults, connectivity patterns obtained from this dataset may mis-
represent the altered networked architecture typically observed in 
individuals with epilepsy (13, 43). Exploiting individualized struc-
tural and functional connectome information in patients therefore 
seems to be the logical next step to improve patient-tailored atrophy 
models, and ongoing and future initiatives to share epilepsy con-
nectome data may facilitate this work. Higher-resolution cortical 
and subcortical parcellations, together with individualized connec-
tivity data, may help to resolve the discrepancy between functional 
and structural findings observed in TLE and IGE. Similarly, in-
creased resolution of subcortical data will help identify putative 
disease epicenters of subcortical volume loss and ultimately deepen 
our understanding of epilepsy syndromes characterized by wide-
spread subcortical atrophy, such as IGE, or by profound hippo-
campal and thalamic atrophy, as in TLE. Last, the cross-sectional 
nature of these datasets limited the investigation of effects of disease 
progression to between-subject effects. Age- and disease-related 
effects reported here may also reflect an initial precipitating insult 
(e.g., prolonged febrile seizures or traumatic brain injury) and 
not per se the progression of the disease. Similarly, cross-sectional 
designs are not properly tailored to track gray matter loss over time 
nor its association to clinical features (12). Longitudinal imaging 
studies that follow both patients and controls are needed to disso-
ciate progressive pathological changes from normal aging. Whether 
within-patient changes in cortical and subcortical atrophy are con-
ditioned by network organization also remains an exciting open 
question and awaits further investigation, ideally in prospective and 
large-scale collaborative follow-up studies across the spectrum of 
common epilepsies (12). We hope that our study lays a foundation 
for future longitudinal studies to model the predictive path of atro-
phy in newly diagnosed patients and further results in network- 
based clinical tools that can help to understand the pathophysiology 
of common epilepsies.
MATERIALS AND METHODS
ENIGMA participants
We studied 1021 adults with epilepsy (440 males, mean age ± 
SD = 36.72 ± 11.07 years) and 1564 healthy controls (695 males, 
mean age ± SD = 33.13 ± 10.45 years) obtained from the Epilepsy 
Working Group of ENIGMA (29). Epilepsy specialists at each center 
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diagnosed patients according to the seizure and syndrome classifi-
cations of the International League Against Epilepsy. Inclusion of 
adults with TLE was based on the combination of electroclinical 
features and MRI findings typically associated with underlying 
hippocampal sclerosis. Inclusion of adults with IGE was based on 
the presence of tonic-clonic, absence, or myoclonic seizures with 
generalized spike-wave discharges on electroencephalography. We 
excluded participants with a progressive disease (e.g., Rasmussen’s 
encephalitis), malformations of cortical development, tumors, or 
prior neurosurgery. Local institutional review boards and ethics 
committees approved each included cohort study, and written 
informed consent was provided according to local requirements.
Mega-analysis of cortical thickness and subcortical 
volumetric data
All participants underwent structural T1-weighted MRI scans at 
each of the 19 participating centers, with scanner descriptions and 
acquisition protocols detailed elsewhere (29). Images were inde-
pendently processed by each center using the standard ENIGMA 
workflow. In brief, models of cortical and subcortical surface mor-
phology were generated with FreeSurfer 5.3.0 (44). On the basis 
of the Desikan-Killiany anatomical atlas (30), cortical thickness was 
measured across 68 gray matter brain regions, and volumetric 
measures were obtained from 12 subcortical gray matter regions 
(bilateral amygdala, caudate, nucleus accumbens, pallidum, putamen, 
and thalamus) and bilateral hippocampi. Data were harmonized 
across scanners and sites and statistically corrected for age, sex, and 
intracranial volume using ComBat—a batch-effect correction tool 
that uses a Bayesian framework to improve the stability of the 
parameter estimates (42).
Cortical thickness and volumetric measures were z-scored rela-
tive to site-matched pooled controls and sorted into ipsilateral/
contralateral to the focus. Surface-based linear models compared 
atrophy profiles in patients relative to controls using SurfStat, avail-
able at http://mica-mni.github.io/surfstat. Findings were corrected 
for multiple comparisons using the FDR procedure (31).
Spatial permutation tests
The intrinsic spatial smoothness in two given brain maps may in-
flate the significance of their spatial correlation (28). We thus assessed 
statistical significance of these spatial correlations using spin permu-
tation tests. This framework generates null models of overlap between 
cortical maps by projecting the spatial coordinates of cortical data 
onto the surface spheres, applying randomly sampled rotations (10,000 
repetitions), and reassigning connectivity values (28). The empiri-
cal (i.e., original) correlation coefficients are then compared against 
the null distributions determined by the ensemble of correlation 
coefficients comparing spatially permuted cortical maps. To compare 
spatial overlap between subcortical maps, we used a similar approach 
with the exception that subcortical labels were randomly shuffled as 
opposed to being projected onto spheres.
HCP participants and MRI preprocessing
We selected a group of unrelated healthy adults (n = 207, 83 males, 
mean age ± SD = 28.73 ± 3.73 years, range = 22 to 36 years) from the 
HCP dataset (21). HCP data were acquired on a Siemens Skyra 3T 
and included (i) T1-weighted images [magnetization-prepared rapid 
gradient echo sequence, repetition time (TR) = 2400 ms, echo time 
(TE) = 2.14 ms, field of view (FOV) = 224 × 224 mm2, voxel 
size = 0.7 mm3, 256 slices], (ii) resting-state fMRI [gradient-echo 
echo-planar imaging (EPI) sequence, TR = 720 ms, TE = 33.1 m, 
FOV = 208 × 180 mm2, voxel size = 2 mm3, 72 slices], and (iii) diffu-
sion MRI (spin-echo EPI sequence, TR = 5520 ms, TE = 89.5 ms, FOV = 
210 × 180, voxel size = 1.25 mm3, b-value = 1000/2000/3000 s/mm2, 
270 diffusion directions, 18 b0 images).
HCP data underwent the initiative’s minimal preprocessing (45). In 
brief, resting-state fMRI data underwent distortion and head motion 
corrections, magnetic field bias correction, skull removal, intensity 
normalization, and were mapped to MNI152 space. Noise components 
attributed to head movement, white matter, cardiac pulsation, arterial, 
and large vein–related contributions were automatically removed 
using FIX (FMRIB’s ICA-based X-noiseifier) (46). Preprocessed time 
series were mapped to standard gray ordinate space using a cortical 
ribbon-constrained volume-to-surface mapping algorithm and subse-
quently concatenated to form a single time series. Diffusion MRI data 
underwent b0 intensity normalization and correction for susceptibility 
distortion, eddy currents, and head motion. As with the ENIGMA- 
Epilepsy dataset, high-resolution functional and structural data were 
parcellated according to the Desikan-Killiany atlas (30).
Functional and structural connectivity matrix generation
Normative functional connectivity matrices were generated by com-
puting pairwise correlations between the time series of all 68 cortical 
regions and between all subcortical and cortical regions; negative 
connections were set to zero. Subject-specific connectivity matrices 
were then z-transformed and aggregated across participants to 
construct a group-average functional connectome.
Normative structural connectivity matrices were generated from 
preprocessed diffusion MRI data using MRtrix3 (47). Anatomically- 
constrained tractography was performed using different tissue types 
derived from the T1w image, including cortical and subcortical gray 
matter, white matter, and cerebrospinal fluid (48). Multishell and 
multitissue response functions were estimated (49), and constrained 
spherical deconvolution and intensity normalization were per-
formed (50). The initial tractogram was generated with 40 million 
streamlines, with a maximum tract length of 250 and a fractional 
anisotropy cutoff of 0.06. Spherical-deconvolution informed filter-
ing of tractograms (SIFT2) was applied to reconstruct whole-brain 
streamlines weighted by the cross-sectional multipliers (51). Recon-
structed streamlines were mapped onto the 68 cortical and 14 sub-
cortical (including hippocampus) regions to produce subject-specific 
structural connectivity matrices. The group-average normative 
structural connectome was defined using a distance-dependent 
thresholding procedure, which preserved the edge length distribu-
tion in individual patients (52), and was log transformed to reduce 
connectivity strength variance. Hence, structural connectivity was 
defined by the number of streamlines between two regions (i.e., 
fiber density).
Nodal stress models
Nodal stress models were derived from spatial correlation analyses 
between cortical and subcortical syndrome-specific atrophy profiles 
and normative weighted degree centrality maps. Weighted degree 
centrality was used here to identify structural and functional hub 
regions by computing the sum of all weighted cortico-cortical and 
subcortico-cortical connections for every region (higher degree 
centrality denotes a hub region). Because different centrality mea-
sures can describe different topological roles in brain networks, we 
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replicated the spatial similarity analyses across other nodal metrics, 
including (i) pagerank centrality [proportional to the number of 
steps (or time) spent at each node] and (ii) eigenvector centrality 
(multiple of the sum of adjacent centralities; i.e., takes into account 
nodes that are connected to other highly central nodes). To avoid 
bias in choosing an arbitrary threshold and zeroing potentially use-
ful information, these analyses were carried out on unthresholded 
connectivity matrices.
Mapping disease epicenters
Syndrome-specific epicenters were identified by spatially correlat-
ing every region’s healthy functional and structural connectivity 
profiles to whole-brain patterns of cortical atrophy in TLE and IGE 
(i.e., group-level atrophy maps obtained from surface-based linear 
models comparing these patient cohorts to controls). This approach 
was repeated systematically across the whole brain, assessing the 
statistical significance of the spatial similarity of every region’s 
functional and structural connectivity profiles to syndrome-specific 
atrophy maps with spatial permutation tests. Cortical and subcortical 
epicenter regions were then identified whether their connectivity 
profiles significantly correlated with the disease-specific cortical 
atrophy map; regions with significant associations were ranked in 
descending order based on their correlation coefficients, with highly 
ranked regions representing disease epicenters. Regardless of its 
atrophy level, a cortical or subcortical region could potentially be 
an epicenter if it is (i) strongly connected to other high-atrophy re-
gions and (ii) weakly connected to low-atrophy regions. Moreover, 
disease epicenters also do not necessarily represent hub regions but may 
rather be connected to them (i.e., so-called feeder nodes that directly 
link peripheral nodes to hubs). As with the nodal stress models, we elim-
inated matrix thresholding to ensure that connectivity to every brain 
region was accounted for, thus allowing detection of disease epicen-
ters in areas with subthreshold atrophy. Similarly, and because of the 
low granularity of the subcortical atlas (i.e., one value per subcortical 
structure), we restricted our epicenter approach to cortico- cortical 
and subcortico-cortical connectivity. A schematic of the cortical and 
subcortical disease epicenter mapping approach is displayed in 
Fig. 3A.
To relate disease epicenter findings to the nodal stress model, we 
performed spatial correlations between epicenter-based connectivity 
profiles (i.e., whole-brain connectivity seeding from the epicenter 
region) and maps of cortical degree centrality (showing the spatial 
distribution of hub regions); strong correlations indicated that 
disease epicenters were functionally and structurally connected to 
cortical hub regions. This analysis was individually performed on 
the two highest ranked functional and structural disease epicenters 
in TLE and IGE.
Age- and duration-related effects
To study the negative effects of age on gray matter atrophy profiles, 
we first built linear models that included a group and age main ef-
fect term and a group × age interaction term (11). We then evaluated 
age-related differences on cortical thickness and subcortical volume 
between patients and controls by testing the significance of the in-
teraction term. Linear models independently assessed the effects 
of duration of epilepsy and age of onset on cortical thickness and 
subcortical volume measurements in each patient cohort. We then 
compared these age- and duration-related effect maps to the spatial 
distributions of hub regions and disease epicenters.
Patient-tailored atrophy modeling
Cortical thickness and subcortical volume data in patients were 
z-scored relative to healthy controls to generate individualized atro-
phy maps and were subsequently compared to normative network 
centrality metrics as in the above analysis. Patient-specific atrophy 
maps were also used to identify each patient’s structural and func-
tional disease epicenters by keeping the cortical and subcortical re-
gions whose normative connectivity profiles significantly correlated 
with the patient’s atrophy map. Significance testing for patient- 
specific epicenters were computed with spin permutation tests with 
1000 repetitions.
Reproducibility and sensitivity analyses
Reproducibility in left and right TLE
As seizure focus lateralization may differentially affect the distribu-
tion of gray matter atrophy (29), we repeated the nodal stress, disease 
epicenter, and age-related analyses in left (nLTLE = 391) and right 
(nRTLE = 341) TLE independently.
Reproducibility across sites
To address reproducibility of our findings across different sites, we 
repeated the nodal stress models and disease epicenter analyses in 
each individual site that provided at least five participants per diag-
nostic group (nTLE/HC = 16 sites, nGE/HC = 10 sites).
Stability across matrix thresholds
To verify that results were not biased by the choice of a particular 
threshold, we repeated the network model analyses across the range of 
possible matrix thresholds (i.e., top 1 to 100%, with increments of 1%). 
Functional and structural (i) cortico-cortical and subcortico- cortical 
degree centrality maps and (ii) epicenter-based connectivity profiles 
(obtained from the highest ranked disease epicenter in each patient 
cohort) were derived from thresholded connectivity matrices (computed 
iteratively over all thresholds) and spatially correlated to the cohort- 
specific atrophy maps. Significance testing of these correlations 
was assessed via spin permutation tests with 10,000 repetitions.
Stability across a higher resolution parcellation
In a separate analysis, functional and structural connectivity matri-
ces were parcellated according to the Schaefer atlas that divides the 
cortex into 400 functional areas (32). Because cortical thickness and 
subcortical volume data were only available and shared on the basis 
of the Desikan-Killiany atlas (30), degree centrality and epicenter- 
based connectivity profiles were first computed on Schaefer 400 and 
subsequently averaged within each original 68 cortical regions to 
allow for spatial correlations with the atrophy maps.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/47/eabc6457/DC1
View/request a protocol for this paper from Bio-protocol.
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